Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000245459 | SCV000310586 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Eurofins Ntd Llc |
RCV000245459 | SCV000340194 | benign | not specified | 2016-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000953088 | SCV001099638 | benign | not provided | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001124717 | SCV001283702 | likely benign | Congenital nephrotic syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Gene |
RCV000953088 | SCV001988722 | benign | not provided | 2021-09-07 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 15086927, 20507940, 11317351, 20981092, 26346198, 31216994) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000245459 | SCV002050956 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002294150 | SCV002587294 | likely benign | Focal segmental glomerulosclerosis | 2022-07-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000953088 | SCV004810475 | benign | not provided | 2025-01-01 | criteria provided, single submitter | clinical testing | NPHS1: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV000953088 | SCV005207026 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001275395 | SCV001460544 | benign | Finnish congenital nephrotic syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |